Mutated Coronavirus in US and Europe 10 Times More Contagious Than Original Strain
|
By HospiMedica International staff writers Posted on 01 Jul 2020 |

Image: In this cryogenic electron microscope image of a SARS-CoV-2 spike protein side view, the S1 section of the spike is shown in green and the S2 portion is shown in purple. This unique two-piece system has shown itself to be relatively unstable (Photo courtesy of Andrew Ward lab, Scripps Research)
A tiny genetic mutation in the SARS coronavirus 2 variant circulating throughout Europe and the US has significantly increased the virus’ ability to infect cells.
Lab experiments performed at The Scripps Research Institute (Jupiter, FL, USA) have shown that viruses with the mutation were much more infectious than those without the mutation in the cell culture system used by the researchers. The mutation had the effect of markedly increasing the number of functional spikes on the viral surface that allow the virus to bind to and infect cells. The spikes give the coronavirus its crown-like appearance and enable it to latch onto target cell receptors called ACE2. The mutation, called D614G, provides greater flexibility to the spike’s “backbone” as more flexible spikes allow newly made viral particles to navigate the journey from producer cell to target cell fully intact, with less tendency to fall apart prematurely. The SARS-CoV-2 variant that circulated in the earliest regional outbreaks lacked the D614G mutation now dominating in much of the world, making it about 10 times more infectious than the strain that originally was identified in Asia.
However, the researchers currently do not know whether this small mutation affects the severity of symptoms of infected people, or increases mortality. Additionally, the researchers who performed their biochemical experiments using harmless viruses engineered to produce key coronavirus proteins found that immune factors from the serum of infected people work equally well against engineered viruses both with and without the D614G mutation. This raises hopes that vaccine candidates in development will work against coronavirus variants with or without that mutation.
“Viruses with this mutation were much more infectious than those without the mutation in the cell culture system we used,” said Scripps Research virologist Hyeryun Choe, PhD, senior author of the study. “The number or density of functional spikes on the virus is four or five times greater due to this mutation. Our data are very clear, the virus becomes much more stable with the mutation.”
Related Links:
The Scripps Research Institute
Lab experiments performed at The Scripps Research Institute (Jupiter, FL, USA) have shown that viruses with the mutation were much more infectious than those without the mutation in the cell culture system used by the researchers. The mutation had the effect of markedly increasing the number of functional spikes on the viral surface that allow the virus to bind to and infect cells. The spikes give the coronavirus its crown-like appearance and enable it to latch onto target cell receptors called ACE2. The mutation, called D614G, provides greater flexibility to the spike’s “backbone” as more flexible spikes allow newly made viral particles to navigate the journey from producer cell to target cell fully intact, with less tendency to fall apart prematurely. The SARS-CoV-2 variant that circulated in the earliest regional outbreaks lacked the D614G mutation now dominating in much of the world, making it about 10 times more infectious than the strain that originally was identified in Asia.
However, the researchers currently do not know whether this small mutation affects the severity of symptoms of infected people, or increases mortality. Additionally, the researchers who performed their biochemical experiments using harmless viruses engineered to produce key coronavirus proteins found that immune factors from the serum of infected people work equally well against engineered viruses both with and without the D614G mutation. This raises hopes that vaccine candidates in development will work against coronavirus variants with or without that mutation.
“Viruses with this mutation were much more infectious than those without the mutation in the cell culture system we used,” said Scripps Research virologist Hyeryun Choe, PhD, senior author of the study. “The number or density of functional spikes on the virus is four or five times greater due to this mutation. Our data are very clear, the virus becomes much more stable with the mutation.”
Related Links:
The Scripps Research Institute
Latest COVID-19 News
- Low-Cost System Detects SARS-CoV-2 Virus in Hospital Air Using High-Tech Bubbles
- World's First Inhalable COVID-19 Vaccine Approved in China
- COVID-19 Vaccine Patch Fights SARS-CoV-2 Variants Better than Needles
- Blood Viscosity Testing Can Predict Risk of Death in Hospitalized COVID-19 Patients
- ‘Covid Computer’ Uses AI to Detect COVID-19 from Chest CT Scans
- MRI Lung-Imaging Technique Shows Cause of Long-COVID Symptoms
- Chest CT Scans of COVID-19 Patients Could Help Distinguish Between SARS-CoV-2 Variants
- Specialized MRI Detects Lung Abnormalities in Non-Hospitalized Long COVID Patients
- AI Algorithm Identifies Hospitalized Patients at Highest Risk of Dying From COVID-19
- Sweat Sensor Detects Key Biomarkers That Provide Early Warning of COVID-19 and Flu
- Study Assesses Impact of COVID-19 on Ventilation/Perfusion Scintigraphy
- CT Imaging Study Finds Vaccination Reduces Risk of COVID-19 Associated Pulmonary Embolism
- Third Day in Hospital a ‘Tipping Point’ in Severity of COVID-19 Pneumonia
- Longer Interval Between COVID-19 Vaccines Generates Up to Nine Times as Many Antibodies
- AI Model for Monitoring COVID-19 Predicts Mortality Within First 30 Days of Admission
- AI Predicts COVID Prognosis at Near-Expert Level Based Off CT Scans
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read moreCritical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read moreSurgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel








